These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 8599217)
1. A new form of particulate single and multiple immunogen delivery system based on recombinant bluetongue virus-derived tubules. Mikhailov M; Monastyrskaya K; Bakker T; Roy P Virology; 1996 Mar; 217(1):323-31. PubMed ID: 8599217 [TBL] [Abstract][Full Text] [Related]
2. Synthesis of bluetongue virus chimeric VP3 molecules and their interactions with VP7 protein to assemble into virus core-like particles. Tanaka S; Mikhailov M; Roy P Virology; 1995 Dec; 214(2):593-601. PubMed ID: 8553561 [TBL] [Abstract][Full Text] [Related]
3. Development of HIV/AIDS vaccine using chimeric gag-env virus-like particles. Kang CY; Luo L; Wainberg MA; Li Y Biol Chem; 1999 Mar; 380(3):353-64. PubMed ID: 10223338 [TBL] [Abstract][Full Text] [Related]
4. Presentation of hepatitis B virus preS2 epitope on bluetongue virus core-like particles. Belyaev AS; Roy P Virology; 1992 Oct; 190(2):840-4. PubMed ID: 1381538 [TBL] [Abstract][Full Text] [Related]
5. Formation of immunogenic virus-like particles by inserting epitopes into surface-exposed regions of hamster polyomavirus major capsid protein. Gedvilaite A; Frömmel C; Sasnauskas K; Micheel B; Ozel M; Behrsing O; Staniulis J; Jandrig B; Scherneck S; Ulrich R Virology; 2000 Jul; 273(1):21-35. PubMed ID: 10891404 [TBL] [Abstract][Full Text] [Related]
6. Characterization and modification of the carboxy-terminal sequences of bluetongue virus type 10 NS1 protein in relation to tubule formation and location of an antigenic epitope in the vicinity of the carboxy terminus of the protein. Monastyrskaya K; Gould EA; Roy P J Virol; 1995 May; 69(5):2831-41. PubMed ID: 7535866 [TBL] [Abstract][Full Text] [Related]
7. Characterization of complex B cell epitopes on woodchuck hepatitis virus surface antigens by using plasmids encoding chimeric proteins and DNA immunization. Zheng X; Schirmbeck R; Hilken G; Waters JA; Yang D; Reimann J; Roggendorf M; Lu M Virology; 2002 Mar; 294(2):342-53. PubMed ID: 12009876 [TBL] [Abstract][Full Text] [Related]
8. Virus-derived tubular structure displaying foreign sequences on the surface elicit CD4+ Th cell and protective humoral responses. Ghosh MK; Borca MV; Roy P Virology; 2002 Oct; 302(2):383-92. PubMed ID: 12441082 [TBL] [Abstract][Full Text] [Related]
10. Recombinant human immunodeficiency Pr55gag virus-like particles presenting chimeric envelope glycoproteins induce cytotoxic T-cells and neutralizing antibodies. Deml L; Schirmbeck R; Reimann J; Wolf H; Wagner R Virology; 1997 Aug; 235(1):26-39. PubMed ID: 9300034 [TBL] [Abstract][Full Text] [Related]
11. Assembly and extracellular release of chimeric HIV-1 Pr55gag retrovirus-like particles. Wagner R; Deml L; Fliessbach H; Wanner G; Wolf H Virology; 1994 Apr; 200(1):162-75. PubMed ID: 7510434 [TBL] [Abstract][Full Text] [Related]
12. Immunizations with chimeric hepatitis B virus-like particles to induce potential anti-hepatitis C virus neutralizing antibodies. Vietheer PT; Boo I; Drummer HE; Netter HJ Antivir Ther; 2007; 12(4):477-87. PubMed ID: 17668556 [TBL] [Abstract][Full Text] [Related]
13. Bluetongue virus tubules made in insect cells by recombinant baculoviruses: expression of the NS1 gene of bluetongue virus serotype 10. Urakawa T; Roy P J Virol; 1988 Nov; 62(11):3919-27. PubMed ID: 2845115 [TBL] [Abstract][Full Text] [Related]
14. Analysis of murine B-cell epitopes on bluetongue virus 12 nonstructural protein 1. HaiXiu W; EnCheng S; QingYuan X; Tao Y; Qin Z; YuFei F; JunPing L; Shuang L; Liang S; Jing S; DongLai W Appl Microbiol Biotechnol; 2015 Feb; 99(3):1309-21. PubMed ID: 25343975 [TBL] [Abstract][Full Text] [Related]
15. Construction, expression, and immunogenicity of chimeric HIV-1 virus-like particles. Wagner R; Deml L; Schirmbeck R; Niedrig M; Reimann J; Wolf H Virology; 1996 Jun; 220(1):128-40. PubMed ID: 8659105 [TBL] [Abstract][Full Text] [Related]
16. Characterization of an internal permissive site in the cholera toxin B-subunit and insertion of epitopes from human immunodeficiency virus-1, hepatitis B virus and enterotoxigenic Escherichia coli. Bckström M; Holmgren J; Schödel F; Lebens M Gene; 1995 Nov; 165(2):163-71. PubMed ID: 8522171 [TBL] [Abstract][Full Text] [Related]
17. Specificity of humoral and cellular immune response against recombinant particles of nucleocapsid protein of human hepatitis B virus in rabbits. Isaguliants MG; Kadoshnikov YP; Kalinina TI; Smirnov VD; Wahren B Biochemistry (Mosc); 1998 May; 63(5):551-8. PubMed ID: 9632891 [TBL] [Abstract][Full Text] [Related]
18. Presentation of two epitopes of the preS2 region of hepatitis B virus on live recombinant bacteria. Charbit A; Sobczak E; Michel ML; Molla A; Tiollais P; Hofnung M J Immunol; 1987 Sep; 139(5):1658-64. PubMed ID: 2442253 [TBL] [Abstract][Full Text] [Related]
19. Hybrid hepatitis B virus core antigen as a vaccine carrier moiety: I. presentation of foreign epitopes. Schödel F; Peterson D; Hughes J; Wirtz R; Milich D J Biotechnol; 1996 Jan; 44(1-3):91-6. PubMed ID: 8717391 [TBL] [Abstract][Full Text] [Related]
20. Release of bluetongue virus-like particles from insect cells is mediated by BTV nonstructural protein NS3/NS3A. Hyatt AD; Zhao Y; Roy P Virology; 1993 Apr; 193(2):592-603. PubMed ID: 8384747 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]